Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals

Nephrology

Volumn 16, Issue 7, 2011, Pages 642-648

  Yoshida, Tetsuro ^a   Kato, Kimihiko ^b,c   Horibe, Hideki ^d   Oguri, Mitsutoshi ^e   Fukuda, Michio ^f   Satoh, Kei ^g   Aoyagi, Yukitoshi ^h   Shinkai, Shoji ^h   Nozawa, Yoshinori ⁱ   Yamada, Yoshiji ^c  

^a Inabe General Hospital   (Japan)

^b Meitoh Hospital   (Japan)

^c MIE UNIVERSITY   (Japan)

^d GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^e JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g HIROSAKI UNIVERSITY   (Japan)

^h TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

ⁱ Tokai Women's Junior College   (Japan)

Author keywords

chronic; genetic polymorphism; genetics; kidney failure; molecular epidemiology; renal insufficiency

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BTN 2A1 GENE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NUCLEAR FACTOR 90 PROTEINS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 80052103903     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01470.x     Document Type: Article

References (30)

1. Imai E, Horio M, Yamagata K, et al,. Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study. Hypertens. Res. 2008; 31: 433-41. (Pubitemid 351597496)
2. Weiner DE, Tighiouart H, Amin MG, et al,. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J. Am. Soc. Nephrol. 2004; 15: 1307-15. (Pubitemid 38526012)
3. Jafar TH, Stark PC, Schmid CH, et al,. AIPRD Study Group. Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann. Intern. Med. 2003; 139: 244-52.
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (2 Suppl 1): S1-S266.
5. Yamagata K, Ishida K, Sairenchi T, et al,. Risk factors for chronic kidney disease in a community-based population: A 10-year follow-up study. Kidney Int. 2007; 71: 159-66. (Pubitemid 46094690)
6. Yoshida T, Kato K, Yokoi K, et al,. Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension. Hypertens. Res. 2009; 32: 411-18.
7. Kottgen A, Kao WH, Hwang SJ, et al,. Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med. Genet. 2008; 9: 49.
8. Hanson RL, Craig DW, Millis MP, et al,. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 2007; 56: 975-83. (Pubitemid 46525073)
9. Kao WH, Klag MJ, Meoni LA, et al,. Family Investigation of Nephropathy and Diabetes Research Group. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 2008; 40: 1185-92.
10. Köttgen A, Glazer NL, Dehghan A, et al,. Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. 2009; 41: 712-17.
11. Chambers JC, Zhang W, Lord GM, et al,. Genetic loci influencing kidney function and chronic kidney disease. Nat. Genet. 2010; 42: 373-5.
12. Köttgen A, Pattaro C, Böger CA, et al,. New loci associated with kidney function and chronic kidney disease. Nat. Genet. 2010; 42: 376-84.
13. Yamada Y, Nishida T, Ichihara S, et al,. Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations. Atherosclerosis 2011; 215: 145-52.
14. McCullough PA, Li S, Jurkovitz CT, et al,. KEEP Investigators. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am. Heart J. 2008; 156: 277-83.
15. Schiffrin EL, Lipman ML, Mann JF,. Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007; 116: 85-97. (Pubitemid 47016250)
16. Matsuo S, Imai E, Horio M, et al,. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 2009; 53: 982-92.
17. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351: 1296-305.
18. Yoshida T, Kato K, Fujimaki T, et al,. Association of genetic variants with chronic kidney disease in Japanese individuals. Clin. J. Am. Soc. Nephrol. 2009; 4: 883-90.
19. Yoshida T, Kato K, Yokoi K, et al,. Association of gene polymorphisms with chronic kidney disease in Japanese individuals. Int. J. Mol. Med. 2009; 24: 539-47.
20. Yoshida T, Kato K, Fujimaki T, et al,. Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome. Genomics 2009; 93: 221-6.
21. Itoh Y, Mizuki N, Shimada T, et al,. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005; 57: 717-29. (Pubitemid 41598618)
22. Malcherek G, Mayr L, Roda-Navarro P, Rhodes D, Miller N, Trowsdale J,. The B7 homolog butyrophilin BTN2A1 is a novel ligand for DC-SIGN. J. Immunol. 2007; 179: 3804-11.
23. Arnett HA, Escobar SS, Viney JL,. Regulation of costimulation in the era of butyrophilins. Cytokine 2009; 46: 370-5.
24. Ogg SL, Weldon AK, Dobbie L, Smith AJ, Mather IH,. Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets. Proc. Natl. Acad. Sci. USA 2004; 101: 10084-9. (Pubitemid 38891198)
25. Valentonyte R, Hampe J, Huse K, et al,. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 2005; 37: 357-64.
26. Mochida A, Kinouchi Y, Negoro K, et al,. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1 1502. Tissue Antigens. 2007; 70: 128-35. (Pubitemid 47028456)
27. Orozco G, Eerligh P, Sánchez E, et al,. Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Hum. Immunol. 2005; 66: 1235-41.
28. Traherne JA, Barcellos LF, Sawcer SJ, et al,. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1 15. Hum. Mol. Genet. 2006; 15: 155-61. (Pubitemid 43020113)
29. Keane WF, Kasiske BL, O'Donnell MP, Kim Y,. Hypertension, hyperlipidemia, and renal damage. Am. J. Kidney Dis. 1993; 21 (5 Suppl 2): 43-50. (Pubitemid 23158796)
30. Fassett RG, D'Intini V, Healy H, et al,. Assessment of arterial stiffness, oxidative stress and inflammation in acute kidney injury. BMC Nephrol. 2009; 10: 15.